Matches in Wikidata for { <http://www.wikidata.org/entity/Q61938159> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q61938159 description "assaig clínic" @default.
- Q61938159 description "clinical trial" @default.
- Q61938159 description "clinical trial" @default.
- Q61938159 description "clinical trial" @default.
- Q61938159 description "clinical trial" @default.
- Q61938159 description "ensaio clínico" @default.
- Q61938159 description "ensayo clínico" @default.
- Q61938159 description "ensayu clínicu" @default.
- Q61938159 description "essai clinique" @default.
- Q61938159 description "klinisch onderzoek" @default.
- Q61938159 description "клінічне випробування" @default.
- Q61938159 description "临床试验" @default.
- Q61938159 name "Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)" @default.
- Q61938159 type Item @default.
- Q61938159 label "Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)" @default.
- Q61938159 prefLabel "Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)" @default.
- Q61938159 P1050 Q61938159-45C57A5B-17D2-43F8-879F-523FCFAA7F3F @default.
- Q61938159 P1132 Q61938159-CC6739BA-07A5-4DD3-9D32-518E32ABC346 @default.
- Q61938159 P1476 Q61938159-30E6F8F8-F77E-45CB-806B-50D302FD1331 @default.
- Q61938159 P1813 Q61938159-9C18D4E5-C16A-475E-8A6F-F815EEEC648A @default.
- Q61938159 P2899 Q61938159-D1AEB8EE-A76D-4B26-83D5-85AA141E504F @default.
- Q61938159 P3098 Q61938159-67D3D9D6-DD04-40AD-8BD7-03F988A87445 @default.
- Q61938159 P31 Q61938159-4C5CB39C-199C-4530-A678-8C7A7DDFF63D @default.
- Q61938159 P4844 Q61938159-46AC8908-53D8-4C0F-824F-4FB9C709C47B @default.
- Q61938159 P580 Q61938159-2871D1D3-9046-4922-984C-81C5CB0A2D76 @default.
- Q61938159 P582 Q61938159-0EAA13CC-3456-4F75-A593-78F791A8FF97 @default.
- Q61938159 P8005 Q61938159-3FB3FDB7-C0F9-4CA2-BC1A-ACC16F9D22B4 @default.
- Q61938159 P8363 Q61938159-98926136-2CA5-4135-BEDA-9B774399C629 @default.
- Q61938159 P921 Q61938159-3D550977-CE5A-45E2-9363-9FCB7534179F @default.
- Q61938159 P921 Q61938159-D5569E6F-D342-4612-AF86-9885F9D74DFA @default.
- Q61938159 P1050 Q179945 @default.
- Q61938159 P1132 "+547" @default.
- Q61938159 P1476 "Post-authorization, Observational Study to Evaluate the Effectiveness of Adalimumab (HUMIRA®) on Moderate-severe Psoriasis Under Conditions of Routine Clinical Practice in Spain." @default.
- Q61938159 P1813 "PROMISE" @default.
- Q61938159 P2899 "+18" @default.
- Q61938159 P3098 "NCT01076192" @default.
- Q61938159 P31 Q30612 @default.
- Q61938159 P4844 Q348260 @default.
- Q61938159 P580 "2010-02-01T00:00:00Z" @default.
- Q61938159 P582 "2014-09-01T00:00:00Z" @default.
- Q61938159 P8005 Q76651189 @default.
- Q61938159 P8363 Q818574 @default.
- Q61938159 P921 Q10566551 @default.
- Q61938159 P921 Q1296024 @default.